Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Efficacy of Aponeurectomy on the 2-year Recurrence Rate of Dupuytren's Disease [NA]

View source ↗

Summary

Clinical trial evaluating whether aponeurectomy reduces the 2-year recurrence rate in Dupuytren's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Elsan | Conditions: Dupuytren's Disease | NA | Status: RECRUITING